Follow BPI on Twitter
April 2010
April 2010 Supplement, Vol.8 No.2
On the Cover
Pall Life Sciences (www.pall.com)
Disposables
Todd Kapp, John Boehm, Jeff Chase, Jeff Craig, Ken Davis, Vikas Gupta, John Stover, Steve Wilkowski, S. Anne Montgomery, Kevin Ott
BioProcess International, Vol. 8, No. S4, April 2010, pp. 10–19
Ran Zheng
BioProcess International, Vol. 8, No. S4, April 2010, pp. 4–9
Chapter 1
William G. Whitford
BioProcess International, Vol. 8, No. S4, April 2010, pp. 20–27
Chapter 2
John Boehm
BioProcess International, Vol. 8, No. S4, April 2010, pp. 32–35
Chapter 3
Michael A. Ruberto
BioProcess International, Vol. 8, No. S4, April 2010, pp. 36–41
Emilie Gautriaud, Keith T. Stafford, Jennifer Adamchuk, Mark W. Simon, Duan Li Ou
BioProcess International, Vol. 8, No. S4, April 2010, pp. 42–49
Biopharmaceutical Production
Facility Design Strategies for Single-Use Technologies
Facility Design Strategies for Single-Use Technologies
Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:
Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST
Presented by:
Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences
During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:
* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility
Nine Conferences — One Location: Hilton Bayfront (San Diego, CA)
Development of a Plant-Made Pharmaceutical Production Platform
Recommendations for Cell Banks Used in GXP Assays
Efficient Aggregate Removal from Impure Pharmaceutical Active Antibodies
Implementation of Single-Use Technology in Biopharmaceutical Manufacturing
Production and Purification of a PER.C6-Expressed IgM Antibody Therapeutic
How QbD and the FDA Process Validation Guidance Affect Product Development and Operations, Part 2